|
|
|
|
|
|
|
The Rare Disease Patients Experience
|
|
When planning a clinical trial for a rare disease, it is important to have a holistic understanding of your patient population. You want to be aware of where your patients are coming from, and what it is like to walk in their shoes. These patients need your trial just as much as you need them; even from the earliest stages, conceptualize your rare disease trial as an altruistic relationship between the patient population and your study.
|
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Merck Introduces Parteck® COAT Excipient, a Fast-Dissolving Material for Immediate Release Coating
• Designed to simplify the formulation and coating process for tablets
• Optimized particle size leads to fast dissolving and increases coating process efficiency
Merck has launched its
Parteck® COAT excipient, a new functional material designed for
immediate release film coating applications. Parteck® COAT is a particle
engineered polyvinyl alcohol (PVA) with a unique particle structure
that enables rapid dissolution even at low temperatures leading to an
increased process efficiency.
More info >> |
|
 |
White Papers |
 |
|
 |
Industry Events |
 |
Outsourcing in Clinical Trials Europe
26-27 October 2020, Paris, France
Arena International are delighted to announce the return of Outsourcing
in Clinical Trials Europe. Part of our global series of events, this
flagship show will attract the leading clinical professionals from
across Europe. The 10th Annual event will be hosted in Paris.
More info >> |
|
|
|
